HomeCompareAPEN vs VICI

APEN vs VICI: Dividend Comparison 2026

APEN yields 20.00% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $893.2K in total portfolio value· pulled ahead in Year 6
10 years
APEN
APEN
● Live price
20.00%
Share price
$10.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$73.0K
Annual income
$6,738.96
Full APEN calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — APEN vs VICI

📍 VICI pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPENVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APEN + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APEN pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APEN
Annual income on $10K today (after 15% tax)
$1,700.00/yr
After 10yr DRIP, annual income (after tax)
$5,728.12/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $510,541.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APEN + VICI for your $10,000?

APEN: 50%VICI: 50%
100% VICI50/50100% APEN
Portfolio after 10yr
$519.6K
Annual income
$307,057.54/yr
Blended yield
59.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

APEN
Analyst Ratings
4
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$9.50
-5.0% upside vs current
Range: $9.00 — $10.00
Altman Z
0.7
Piotroski
3/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APEN buys
0
VICI buys
0
No recent congressional trades found for APEN or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPENVICI
Forward yield20.00%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$73.0K$966.2K
Annual income after 10y$6,738.96$607,376.13
Total dividends collected$41.5K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$9.50$31.60

Year-by-year: APEN vs VICI ($10,000, DRIP)

YearAPEN PortfolioAPEN Income/yrVICI PortfolioVICI Income/yrGap
1$12,700$2,000.00$11,361$941.49+$1.3KAPEN
2$15,963$2,373.83$13,320$1,481.32+$2.6KAPEN
3$19,869$2,788.51$16,284$2,405.01+$3.6KAPEN
4$24,503$3,243.76$21,040$4,071.78+$3.5KAPEN
5$29,957$3,738.69$29,209$7,285.49+$748.00APEN
6← crossover$36,326$4,271.82$44,443$14,006.51$8.1KVICI
7$43,710$4,841.12$75,822$29,512.55$32.1KVICI
8$52,214$5,444.08$148,733$69,726.75$96.5KVICI
9$61,947$6,077.78$344,394$189,413.75$282.4KVICI
10$73,022$6,738.96$966,234$607,376.13$893.2KVICI

APEN vs VICI: Complete Analysis 2026

APENStock

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Full APEN Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this APEN vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APEN vs SCHDAPEN vs JEPIAPEN vs OAPEN vs KOAPEN vs MAINAPEN vs NNNAPEN vs EPRTAPEN vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.